Effective Triple-Negative Breast Cancer Targeted Treatment Using iRGD-Modified RBC Membrane-Camouflaged Nanoparticles

INTRODUCTION: Triple-negative breast cancer (TNBC) has the high degree of malignancy and aggressiveness. There is no targeted therapy drug. Many studies have shown that RBC membrane-coated nanoparticles achieve biological camouflage. In addition, the RGD module in the iRGD mediates the penetration o...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jingbin, Lai, Wenjing, Wang, Qing, Tang, Qin, Hu, Changpeng, Zhou, Min, Wang, Fengling, Xie, Dandan, Zhang, Qian, Liu, Wuyi, Zhang, Zhe, Zhang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596023/
https://www.ncbi.nlm.nih.gov/pubmed/34803378
http://dx.doi.org/10.2147/IJN.S321071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596023/
https://www.ncbi.nlm.nih.gov/pubmed/34803378
http://dx.doi.org/10.2147/IJN.S321071

Ejemplares similares